Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06297226
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-02-28
Brief Title:
Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
Juno Therapeutics Inc a Bristol-Myers Squibb Company
Organization:
Juno Therapeutics Inc a Bristol-Myers Squibb Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-06-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-28
First Submit QC Date:
February 28 2024
Study First Post Date:
2024-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-14
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL